EIDD-1931
EIDD-1931 (Beta-d-N4-hydroxycytidine; NHC) is a novel nucleoside analog and behaves as a potent anti-virus agent. EIDD-1931 effectively inhibits the replication activity of venezuelan equine encephalitis virus (VEEV), Chikungunya virus (CHIKV) and hepatitis C virus (HCV) [1].
Product Specifications
CAS Number
3258-02-4
Product Name Alternative
β-D-N4-hydroxycytidine; NHC
UNSPSC
12352005
Hazard Statement
H228, H315, H319
Target
CHIKV; Enterovirus; HCV; SARS-CoV; Topoisomerase
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
Neuroscience-Neuromodulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/beta-d-n4-hydroxycytidine.html
Purity
99.98
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 25 mg/mL
Smiles
O=C(N/1)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=CC1=N/O
Molecular Formula
C9H13N3O6
Molecular Weight
259.22
Precautions
H228, H315, H319
References & Citations
4
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Rat Uncharacterized protein C3orf19 homolog
Recombinant Rat Uncharacterized protein C3orf19 homolog
Recombinant Rat Uncharacterized protein C3orf19 homolog
Recombinant Rat Uncharacterized protein C3orf19 homolog
Recombinant Rat Uncharacterized protein C3orf19 homolog